Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program

REFERENCES

• Brandel J-P, Salomon D, Capek I, Vaillant V, Alpérovitch A. Epidemiological surveillance of Creutzfeldt-Jakob in France. Rev Neurol (Paris) 2009; 165:684–93; PMID:19467685; http://dx.doi.org/10.1016/j.neurol.2009.04.006
   PubMedGoogle Scholar
• Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, Zhang BY, Jiang HY, Zhang J, Dong XP. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One 2011; 6:e24231; PMID:21904617; http://dx.doi.org/10.1371/journal.pone.0024231
   PubMed Web of Science ®Google Scholar
• Sanjo N, Mizusawa H. Prion disease - the characteristics and diagnostic points in Japan. Clin Neurol 2010; 50:287–300; PMID:20535976
   PubMedGoogle Scholar
• Begue C, Martinetto H, Schultz M, Rojas E, Romero C, D'Giano C, Sevlever G, Somoza M, Taratuto AL. Creutzfeldt-Jakob disease surveillance in Argentina, 1997–2008. Neuroepidemiology 2011; 37:193–202; PMID:22067221; http://dx.doi.org/10.1159/000331907
   PubMed Web of Science ®Google Scholar
• Choi SI JB, Kim YS. Development of policy and strategy for the control of Creutzfeldt-Jakob Disease in Korea. Korean J Epidemiol 2005; 27:81–9
   Google Scholar
• Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Eng J Med 1996; 335:924–30; PMID:8782499; http://dx.doi.org/10.1056/NEJM199609263351303
   PubMed Web of Science ®Google Scholar
• Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012; 79:1499–506; PMID:22993290; http://dx.doi.org/10.1212/WNL.0b013e31826d5fc3
   PubMed Web of Science ®Google Scholar
• Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PH, Jansen GH, Bulk S, Baas F, van Gool WA. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 2000; 55:514–6; PMID:10953182; http://dx.doi.org/10.1212/WNL.55.4.514
   PubMed Web of Science ®Google Scholar
• Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32–40; PMID:9450766; http://dx.doi.org/10.1002/ana.410430109
   PubMed Web of Science ®Google Scholar
• Green AJ. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Biochem Soc Trans 2002; 30(4):382–86; PMID:12196099; http://dx.doi.org/10.1042/BST0300382
   PubMedGoogle Scholar
• Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Geneva, Switzerland: WHO; 1998.
   Google Scholar
• Jeong BH, Lee KH, Kim NH, Jin JK, Kim JI, Carp RI, Kim YS. Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics 2005; 6:229–32; PMID:16217673; http://dx.doi.org/10.1007/s10048-005-0016-y
   PubMed Web of Science ®Google Scholar
• Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010; 133:3043–57; PMID:20855418; http://dx.doi.org/10.1093/brain/awq216
   PubMed Web of Science ®Google Scholar
• Jang J-W, Park YH, Lim JS, Park SC, Cheong H-K, Kim JE, Kim SY. Neurologists' awareness and preparedness on prion diseases in Korea. Dement Neurocognitive Disord 2013; 12:9–20; http://dx.doi.org/10.12779/dnd.2013.12.1.9
   Google Scholar
• Nakamura Y, Yanagawa H, Hoshi K, Yoshino H, Urata J, Sato T. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999; 28:130–4; PMID:10195677; http://dx.doi.org/10.1093/ije/28.1.130
   PubMedGoogle Scholar
• Lu CJ, Sun Y, Chen SS. Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance. Eur J Epidemiol 2010; 25:341–7; PMID:20333444; http://dx.doi.org/10.1007/s10654-010-9446-4
   PubMed Web of Science ®Google Scholar
• Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, Stewart G, Zeidler M, McKenzie JM, Knight RS, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry 2011; 82:646–51; PMID:21172857; http://dx.doi.org/10.1136/jnnp.2010.232264
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003; 60:813–6; PMID:12810484; http://dx.doi.org/10.1001/archneur.60.6.813
   PubMedGoogle Scholar
• Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J Neurol 2009; 256:1540–50; PMID:19418113; http://dx.doi.org/10.1007/s00415-009-5160-0
   PubMed Web of Science ®Google Scholar
• Matsui Y, Satoh K, Miyazaki T, Shirabe S, Atarashi R, Mutsukura K, Satoh A, Kataoka Y, Nishida N. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease. BMC Neurol 2011; 11:120; PMID:21970675; http://dx.doi.org/10.1186/1471-2377-11-120
   PubMed Web of Science ®Google Scholar
• Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129:2278–87; PMID:16816392; http://dx.doi.org/10.1093/brain/awl159
   PubMed Web of Science ®Google Scholar
• Green AJ, Ramljak S, Muller WE, Knight RS, Schroder HC. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett 2002; 324:57–60; PMID:11983294; http://dx.doi.org/10.1016/S0304-3940(02)00172-6
   PubMed Web of Science ®Google Scholar